GLP-1 First Month: What to Expect, Week by Week Tracking

The Titrra Editorial Team··9 min read
A woman sitting calmly at a sunlit table, writing in a wellness journal to track her weekly progress.

GLP-1 First Month: What to Expect, Week by Week Tracking

Starting a GLP-1 medication is a bit like moving to a new city. The map looks straightforward on paper, but the lived experience, the small adjustments, the "oh, that's what that feels like" moments, only come with time. If you're wondering what the first month on Ozempic, Wegovy, Mounjaro, or Zepbound actually looks like, this guide walks through it week by week, with simple things worth tracking along the way.

This is general education, not a prediction of your personal experience. Everyone's timeline differs, and your clinician is the best resource for anything specific to your health.

Why Week-by-Week Tracking Helps

GLP-1 medications work gradually. According to the NHS, semaglutide reduces appetite and slows digestion, which is part of why early changes can feel subtle rather than dramatic. Tracking helps you notice patterns that are easy to miss in the moment, like which day side effects peak, or when your appetite actually shifts.

A simple log doesn't need to be complicated. Just a few notes each day about how you're feeling, what you ate, and any symptoms can turn a blurry first month into useful information you can bring to appointments.

Week One: Getting Started

The first week is often about logistics as much as biology.

  • Confirm your injection day and time, and note it somewhere visible.
  • If you're navigating insurance steps before your first dose, tracking prior authorization and appeals can save frustration later.
  • Many people feel little to nothing in week one, while others notice mild nausea or fatigue within the first day or two.
  • If you're also managing vaccinations around this time, it's worth reviewing how to time shots safely.

What to track: injection day/time, dose, any immediate reactions at the injection site, and general energy levels.

Week Two: Early Side Effects

This is often when gastrointestinal side effects become more noticeable. The NHS lists nausea, vomiting, constipation, diarrhea, and fatigue among the common side effects of semaglutide.

Helpful things to track this week:

  • Meal timing and portion sizes, since smaller, slower meals are often easier to tolerate
  • Hydration and fiber intake, both of which can ease digestive adjustment (more on tracking fiber here)
  • Any headaches, and whether they correlate with dosing day (tracking headache patterns)
  • Sleep quality, since some people report unusually vivid dreams during this adjustment period (read more on that here)

If you notice swelling, rash, or difficulty breathing, these are not typical adjustment symptoms. The NHS lists allergic reaction as a possible serious side effect, so it's worth knowing the warning signs to watch for and contacting your care team promptly if they appear.

Week Three: Appetite and Routine Shifts

By week three, many people start noticing appetite changes more clearly, feeling fuller sooner, or thinking about food less often. This is also when dose-day fatigue can become more predictable for some, making it a good time to plan lighter tasks around your injection day.

Worth tracking:

Week Four: Settling Into a Pattern

By the end of the first month, many people have a clearer sense of how their body responds to the medication. Some will be approaching a dose adjustment conversation with their prescriber, which is entirely normal and part of the process outlined in clinical guidance.

Things worth noting as you close out the month:

A Note on Medical Guidance and Eligibility

GLP-1 medications like semaglutide and tirzepatide are prescribed within specific clinical frameworks. In the UK, NICE guidance notes that these medicines should be used alongside a reduced-calorie diet and increased physical activity, and that treatment decisions should involve a full discussion between patient and clinician. NICE also notes that progress is typically reviewed, for example at the six-month mark, to decide whether to continue treatment.

The MHRA has also updated its guidance to strengthen warnings around acute pancreatitis and other safety considerations, a reminder that these are genuine medical treatments requiring professional oversight, not quick fixes.

Practical Housekeeping for Month One

A few logistical items tend to come up early and are easy to overlook:

Bringing It All Together

The first month on a GLP-1 medication is rarely a straight line. Some weeks feel uneventful, others bring a side effect you weren't expecting, and that's normal. The goal of tracking isn't to judge how well you're doing, it's simply to notice patterns so you and your clinician have real information to work with.

Keep your notes simple, be patient with the adjustment period, and remember that any concerning symptoms, especially those resembling an allergic reaction or severe abdominal pain, warrant a prompt call to your care team rather than a wait-and-see approach.